Raphas (Korea) Top Management
214260 Stock | KRW 15,920 310.00 1.99% |
Analysis of Raphas' management performance can provide insight into the company performance.
Dohyeon Jeong Insider Chief Officer |
Raphas |
Raphas Management Team Effectiveness
The company has return on total asset (ROA) of (0.0473) % which means that it has lost $0.0473 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.7106) %, meaning that it generated substantial loss on money invested by shareholders. Raphas' management efficiency ratios could be used to measure how well Raphas manages its routine affairs as well as how well it operates its assets and liabilities.Raphas Workforce Comparison
Raphas Co is number one stock in number of employees category among its peers. The total workforce of Personal Products industry is presently estimated at about 88.0. Raphas totals roughly 61.0 in number of employees claiming about 69% of equities listed under Personal Products industry.
The company has Profit Margin (PM) of (0.3) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.3) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.3. Raphas Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Raphas Price Series Summation is a cross summation of Raphas price series and its benchmark/peer.
Raphas Stakeholder
Dohyeon Jeong | Chief Officer | Profile |
About Raphas Management Performance
The success or failure of an entity such as Raphas often depends on how effective the management is. Raphas management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Raphas management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Raphas management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Raphas Co., Ltd. provides skin-based drug delivery systems in South Korea, Japan, and China. The company was founded in 2006 and is headquartered in Seoul, South Korea. RAPHAS is traded on Korean Securities Dealers Automated Quotations in South Korea.
Please note, the presentation of Raphas' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Raphas' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Raphas' management manipulating its earnings.
Raphas Workforce Analysis
Traditionally, organizations such as Raphas use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Raphas within its industry.Raphas Manpower Efficiency
Return on Raphas Manpower
Revenue Per Employee | 333.4M | |
Net Income Per Employee | 77.1M |
Complementary Tools for Raphas Stock analysis
When running Raphas' price analysis, check to measure Raphas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Raphas is operating at the current time. Most of Raphas' value examination focuses on studying past and present price action to predict the probability of Raphas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Raphas' price. Additionally, you may evaluate how the addition of Raphas to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |